Evaluation of Cytogenetic Alterations in Patients of Chronic Kidney Disease

Ravindra M Samarth1,2, Rajnarayan R Tiwari2, Gopesh Modi3

  • 1ICMR-Department of Research, Bhopal Memorial Hospital and Research Centre (ICMR-BMHRC), Bhopal, Madhya Pradesh, India.

PubMed
Abstract

Insights

This study investigated cytogenetic damage in individuals with chronic kidney disease (CKD) and toxic gas exposure. Results indicate that CKD itself, rather than gas exposure, is primarily responsible for observed cytogenetic alterations.

Area of Science:

  • Environmental Health
  • Toxicology
  • Genetics

Background:

  • Chronic kidney disease (CKD) is a growing global health concern, projected to be the fifth leading cause of death by 2040.
  • Besides common risk factors, environmental toxins from pollution or industrial disasters are implicated in multi-organ damage, including kidney pathology.
  • Limited research exists on cytogenetic damage in populations exposed to toxic gases, particularly those with CKD.

Purpose of the Study:

  • To assess the independent impact of CKD on cytogenetic damage.
  • To evaluate the role of toxic gas exposure in cytogenetic alterations among individuals with and without CKD.
  • To investigate potential links between CKD, toxic gas exposure, and genetic damage.

Main Methods:

  • A multi-group cross-sectional study involving 608 participants.
  • Evaluation of cytogenetic alterations using chromosomal aberration analysis and micronuclei assay.
  • Participants were categorized into four groups based on toxic gas exposure history and CKD status.

Main Results:

  • No significant difference in cytogenetic damage was found between gas-exposed and non-exposed CKD patients.
  • Gas-exposed participants with CKD exhibited significantly higher cytogenetic damage compared to gas-exposed individuals without CKD.
  • These findings suggest that CKD is a significant contributor to observed cytogenetic changes.

Conclusions:

  • Cytogenetic alterations in the studied population are partly attributable to chronic kidney disease itself.
  • The study highlights the intrinsic role of CKD in inducing genetic damage.
  • Further research may elucidate the specific mechanisms by which CKD affects cytogenetics.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
20
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
28
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
16
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
11
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
21
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
114